Moderna stock surges 17% on coronavirus vaccine trial newsCurrent / By admin Trial vaccine elicits ‘robust’ immune-system response in larger group of people, Moderna said. Facebook Twitter Google+ Email Tumblr LinkedIn Pinterest WhatsApp Messenger Reddit